-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
-
Summary
-
Propanc Biopharma, Inc. quarterly/annual Depreciation history and growth rate from 2011 to 2024.
- Propanc Biopharma, Inc. Depreciation for the quarter ending June 30, 2024 was $0.000, a 100% decline year-over-year.
- Propanc Biopharma, Inc. Depreciation for the twelve months ending June 30, 2024 was $297.000, a 82.2% decline year-over-year.
- Propanc Biopharma, Inc. annual Depreciation for 2024 was $297.000, a 82.2% decline from 2023.
- Propanc Biopharma, Inc. annual Depreciation for 2023 was $1.67K, a 16.5% decline from 2022.
- Propanc Biopharma, Inc. annual Depreciation for 2022 was $1.99K, unchanged from 2021.
Depreciation, Trailing 12 Months (USD)
Depreciation, Annual (USD)
Depreciation, YoY Annual Growth (%)